Cargando…
Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
BACKGROUND: Cambodia is the epicentre of the emergence of Plasmodium falciparum drug resistance. Much less is known regarding the drug susceptibility of the co-endemic Plasmodium vivax. Only in vitro drug assays can determine the parasite’s intrinsic susceptibility, but these are challenging to impl...
Autores principales: | Roesch, Camille, Mairet-Khedim, Mélissa, Kim, Saorin, Lek, Dysoley, Popovici, Jean, Witkowski, Benoit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303819/ https://www.ncbi.nlm.nih.gov/pubmed/32211790 http://dx.doi.org/10.1093/jac/dkaa092 |
Ejemplares similares
-
Therapeutic and Transmission-Blocking
Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
por: Popovici, Jean, et al.
Publicado: (2018) -
Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia
por: Mairet-Khedim, Mélissa, et al.
Publicado: (2022) -
Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia
por: Mairet-Khedim, Melissa, et al.
Publicado: (2020) -
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India
por: Gargano, Nicola, et al.
Publicado: (2012) -
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
por: Duru, Valentine, et al.
Publicado: (2015)